CORT
Corcept Therapeutics Incorporated
26.57
USD
This page is just a preview of the data found in TrendSpider’s full version
Corcept Therapeutics Incorporated stock is up 6.15% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45% of the previous 19 December’s closed higher than November. In the last 8 Unusual Options Trades, there were 2 CALLs, 6 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 20 Oct 17:54 | 17 Nov, 2023 | 34.00 | 5 | ||
| 20 Oct 17:54 | 17 Nov, 2023 | 30.00 | 590 | ||
| 02 Nov 19:45 | 17 May, 2024 | 23.00 | 6 | ||
| 02 Nov 19:46 | 17 May, 2024 | 23.00 | 6 | ||
| 02 Nov 19:48 | 17 May, 2024 | 23.00 | 6 | ||
| 02 Nov 19:48 | 17 May, 2024 | 23.00 | 6 | ||
| 02 Nov 19:51 | 17 May, 2024 | 23.00 | 6 | ||
| 02 Nov 19:52 | 17 May, 2024 | 23.00 | 6 |
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the. treatment of hyperglycemia secondary to hypercortisolism in adult patients with. endogenous Cushing's syndrome.
